← Human Trials & Peer-Reviewed Studies
Improving the selenium supply of vegans and omnivores with Brazil nut butter compared to a dietary supplement in a randomized controlled trial.
Plain-language guide to PMID 39891729 (2025): randomized controlled trial of Copper (Supplement).
Key Facts
- PMID
- 39891729
- Journal
- European journal of nutrition
- Year
- 2025
- Study type
- Randomized Controlled Trial
- Authors
- Simon R et al. (9 authors)
- DOI
- 10.1007/s00394-025-03587-z
- Registered trial
- NCT05814874
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Copper (Supplement).
Due to the lower selenium content in plant-based compared to animal-based foods, many vegans do not reach the recommended selenium intake in Europe.
The only plant-based food with high selenium content is the Brazil nut, even though there is also a high variability.
Why It Was Studied
Clinical trials registration number: NCT05814874, April 18 2023.
Who Took Part
The age groups tagged for this paper are adults and middle-aged adults, both men and women.
How the Study Was Run
In design terms this was a randomized and placebo-controlled study.
The participants were allocated by chance, so the Copper (Supplement) group and the comparison group should start out alike.
A placebo (an inactive look-alike) gave the Copper (Supplement) group a baseline to be compared against.
Serum selenium concentrations, glutathione peroxidase 3 (GPX3), and selenoprotein P (SELENOP) were measured at baseline and after intervention.
Additionally, dietary selenium intake was estimated using a five-day dietary protocol.
What Was Measured
The subject headings attached to it are Selenium, Bertholletia, Dietary Supplements, Vegans, Diet, Vegan, Glutathione Peroxidase and Nuts.
The authors tagged it with the keywords Brazil nut, Selenium status, Selenium supplement and Veganism.
What This Means in Plain Language
The paper is a randomized and placebo-controlled study of Copper (Supplement).
Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2025 (European journal of nutrition), a journal based in Germany.
More context: the Copper (Supplement) compound page, all human trials.
Our Notes on the Compound
Copper (Supplement): The active site of cytochrome c oxidase is described as containing copper ions that are essential for electron transfer.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.